昆明(ming)積大制藥(yao)股份有限(xian)公司成(cheng)立于(yu)1993年(nian)8月8日。
積(ji)大制(zhi)藥(yao)(yao)(yao)(yao)的(de)(de)現代(dai)化(hua)(hua)生(sheng)(sheng)產基地(di)位于云南省發展高新技(ji)術產業的(de)(de)基地(di)和外向型經(jing)濟的(de)(de)重要(yao)窗口——昆明國家高新技(ji)術產業開發區(qu),占地(di)面(mian)積(ji)70畝(mu),建筑面(mian)積(ji)5萬(wan)平方米。目前,積(ji)大制(zhi)藥(yao)(yao)(yao)(yao)旗下(xia)子公司包括:專注于銷(xiao)售的(de)(de)昆明積(ji)大藥(yao)(yao)(yao)(yao)品銷(xiao)售有(you)限公司;著眼(yan)于國際化(hua)(hua)醫(yi)(yi)藥(yao)(yao)(yao)(yao)原料的(de)(de)無錫(xi)積(ji)大制(zhi)藥(yao)(yao)(yao)(yao)有(you)限公司;從事(shi)醫(yi)(yi)藥(yao)(yao)(yao)(yao)原料及藥(yao)(yao)(yao)(yao)品進出口業務(wu)的(de)(de)積(ji)大醫(yi)(yi)藥(yao)(yao)(yao)(yao)(香港)貿易有(you)限公司,以(yi)及蘊含高新科(ke)技(ji)項(xiang)目的(de)(de)云南積(ji)華(hua)生(sheng)(sheng)物科(ke)技(ji)有(you)限公司,構建了集(ji)制(zhi)劑生(sheng)(sheng)產、原料生(sheng)(sheng)產、科(ke)研(yan)、銷(xiao)售為一體的(de)(de)集(ji)團化(hua)(hua)模式(shi)。
良好而彈性的生(sheng)產(chan)能(neng)力(li)是(shi)積(ji)大制藥(yao)賴以(yi)實(shi)現企業(ye)戰(zhan)略的核(he)心。制劑生(sheng)產(chan)基地現有十三(san)個車間、十六條生(sheng)產(chan)線(xian),全部(bu)通(tong)過(guo)國家GMP認證,部(bu)分(fen)車間通(tong)過(guo)了(le)國際市場的藥(yao)品認證資質。粉針(zhen)、水針(zhen)、片劑、膠囊劑、顆粒劑、混懸劑、預灌(guan)注等(deng)多(duo)個系列40多(duo)個品種在這具有強大綜合優勢的優良制造(zao)平(ping)臺精心打(da)造(zao),豐富的產(chan)品線(xian),增強了(le)企業(ye)抗風險(xian)能(neng)力(li)。
每條生(sheng)(sheng)產線均(jun)具備高兼容性(xing)和互換(huan)性(xing)的精良配置,在(zai)PMC部對供(gong)、產、銷的動(dong)態(tai)管理下,可根據(ju)市場反饋,實現迅速換(huan)線、換(huan)品種(zhong)生(sheng)(sheng)產,提高了企(qi)業(ye)的應變能(neng)力。
公(gong)(gong)(gong)(gong)司(si)控(kong)(kong)股(gu)(gu)股(gu)(gu)東為積(ji)華藥(yao)業(ye)(ye)(ye)(ye)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(49%),積(ji)華藥(yao)業(ye)(ye)(ye)(ye)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)為在(zai)香港注冊成立的有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si),主要從(cong)事(shi)投資(zi)控(kong)(kong)股(gu)(gu)業(ye)(ye)(ye)(ye)務(wu)(wu)(wu)。其(qi)他主要股(gu)(gu)東為:云南(nan)醫(yi)藥(yao)工(gong)業(ye)(ye)(ye)(ye)股(gu)(gu)份(fen)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(21%),云南(nan)醫(yi)藥(yao)工(gong)業(ye)(ye)(ye)(ye)股(gu)(gu)份(fen)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)為云南(nan)省國(guo)(guo)資(zi)委轄下的醫(yi)藥(yao)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)。光控(kong)(kong)遠創(chuang)醫(yi)藥(yao)投資(zi)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(11.16%),其(qi)是(shi)中國(guo)(guo)光大控(kong)(kong)股(gu)(gu)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)下屬(shu)的境外(wai)投資(zi)控(kong)(kong)股(gu)(gu)公(gong)(gong)(gong)(gong)司(si),從(cong)事(shi)投資(zi)業(ye)(ye)(ye)(ye)務(wu)(wu)(wu)。成都光控(kong)(kong)世紀(ji)醫(yi)療(liao)健康(kang)創(chuang)業(ye)(ye)(ye)(ye)投資(zi)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(5.58%),其(qi)是(shi)中國(guo)(guo)光大控(kong)(kong)股(gu)(gu)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)下屬(shu)的境內(nei)投資(zi)控(kong)(kong)股(gu)(gu)公(gong)(gong)(gong)(gong)司(si),主要從(cong)事(shi)創(chuang)業(ye)(ye)(ye)(ye)投資(zi)業(ye)(ye)(ye)(ye)務(wu)(wu)(wu)。